Posted by on March 4, 2019 2:29 am
Tags:
Categories: Crispr Articles

Source: Adding a Vaccine to Immunotherapy in Lung Cancer: Will It Improve Outcomes? – Cancer Network

[unable to retrieve full-text content]

Adding a Vaccine to Immunotherapy in Lung Cancer: Will It Improve Outcomes?  Cancer Network

Researchers studied the combination of a cellular vaccine known as HS-110 and nivolumab in an early-phase trial of patients with advanced non–small-cell …

Published at Mon, 04 Mar 2019 01:16:11 +0000